LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
24.34
+0.56 (2.35%)
At close: Mar 9, 2026, 4:00 PM EDT
23.87
-0.47 (-1.93%)
After-hours: Mar 9, 2026, 4:14 PM EDT
LB Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 616 | - | - | - |
| Enterprise Value | 305 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.19 | - | -1.12 |
| Net Debt / Equity Ratio | -1.00 | -1.23 | -1.04 | -0.13 |
| Net Debt / EBITDA Ratio | 14.29 | 0.38 | 3.81 | -0.98 |
| Net Debt / FCF Ratio | 13.50 | 0.45 | 3.57 | -1.01 |
| Quick Ratio | 47.31 | 3.45 | 16.61 | 45.64 |
| Current Ratio | 47.60 | 3.56 | 17.51 | 45.82 |
| Return on Equity (ROE) | - | -206.22% | -63.14% | - |
| Return on Assets (ROA) | - | -102.33% | -21.18% | - |
| Return on Capital Employed (ROCE) | -7.00% | -255.00% | -26.40% | -13.40% |
| Buyback Yield / Dilution | -10035.57% | -0.87% | -8.02% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.